康諾亞-B(02162.HK):中期收入達到4.99億元 同比增加812%
格隆匯8月26日丨康諾亞-B(02162.HK)發佈公告,截至2025年6月30日止六個月,實現收入人民幣4.99億元,同比增加812%;毛利爲人民幣4.65億元,同比增加813%;期內虧損爲人民幣7879.9萬元,同比收窄77%;經調整期內虧損爲人民幣6263.4萬元,同比收窄80%;基本每股虧損人民幣0.30元。
報告期內,集團的研發開支主要包括(i)與臨牀前及臨牀研究有關的開支,包括就集團的研發活動聘請CRO及其他服務供應商以及安排臨牀試驗基地的第三方承包成本;(ii)集團研發僱員的員工成本;(iii)採購用於研發候選藥物的原材料及耗材的開支;及(iv)與研發活動有關的物業、廠房及設備以及其他無形資產的折舊及攤銷。截至2025年6月30日止六個月,集團的研發開支由截至2024年6月30日止六個月的人民幣3.31億元增加人民幣2900萬元至人民幣3.60億元。該增加主要歸因於員工成本、臨牀試驗數量及研發活動所用的原材料增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.